NBY News and Press, NovaBay Pharmaceuticals Inc. From 05/27/24

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES MONTRÉAL, May 27, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“ NioBay ” or the “ Company ”) (TSX-V: NBY) (OTCQB: NBYCF) is pleased to announce the...

A look at the top 10 most actives in the United States Greenwave Technology Solutions Inc. (GWAV) fell 55.1% to $0.071 on volume of 238,137,489 shares AgriFORCE Growing Systems Ltd. (AGRI) rose 29.4% to $0.1679 on volume of 103,146,154 shares MGO Global Inc. (MGOL) rose 206.7% to $0.7051 ...

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 16.4% to $0.199 on volume of 720,586,242 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 74.8% to $1.8 on volume of 682,362,254 shares Pineapple Energy Inc. (PEGY) rose 80.3% to $0.1...

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) rose 37.1% to $0.2344 on volume of 300,511,226 shares Faraday Future Intelligent Electric Inc. (FFIE) rose 78.2% to $1.835 on volume of 218,102,513 shares Greenwave Technology Solutions Inc. (GWAV) r...

A look at the top 10 most actives in the United States Crown Electrokinetics Corp. (CRKN) fell 28.8% to $0.171 on volume of 1,679,698,404 shares Faraday Future Intelligent Electric Inc. (FFIE) fell 37.6% to $1.03 on volume of 1,254,842,792 shares Greenwave Technology Solutions Inc. (GWAV)...

Approximately 16 million Americans suffer from dry eye disease with the U.S. market for dry eye treatment projected to reach $4.86 billion by 2030 NovaBay ® Pharmaceuticals, Inc . (NYSE American: NBY), a company developing and commercializing high-quality eyecare and wo...

2024-05-09 16:11:26 ET More on NovaBay NovaBay Pharmaceuticals, Inc. (NBY) Q4 2023 Earnings Call Transcript NovaBay Pharmaceuticals receives NYSE notice for compliance NovaBay Pharmaceuticals show 13% rise in eyecare and wound care segment - prelim report See...

Net product sales increased 13% over the prior year driven by higher sales of Avenova ® -branded products through OTC channels and branded wound care products Sales and marketing expenses declined 15% reflecting continued digital marketing optimization Ordered product sal...

Ordered product sales of Avenova ® -branded products on Amazon.com set back-to-back records in March and April 2024 Enhanced marketing program provides potential for additional growth in the U.S. dry eye disease treatment market projected to reach nearly $5 billion by 2030 ...

MONTREAL, May 07, 2024 (GLOBE NEWSWIRE) -- NioBay Metals Inc. (“NioBay” or the “Company”) (TSX-V: NBY) (OTCQB: NBYCF) is proud to announce that, following re-sampling of historic Vior drill holes from the Foothills Project, assay results confirm the presence of phospha...